Fig. 5 | Scientific Reports

Fig. 5

From: Dual redox effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidene) cyclohexanone (BHMC) on human liver cancer cells, HepG2 via ROS, glutathione and Nrf2/Keap1 pathway

Fig. 5

Effect of BHMC and curcumin on (A) Total Glutathione level (T-GSH), (B) Oxidised Glutathione level (GSSG) and (C) Reduced Glutathione level (GSH) in HepG2 cells at 18- and 24 h of treatments. Glutathione levels were quantified using commercial kits according to the manufacturer’s instructions. Data are presented as mean ± S.E.M. and represent of three independent experiments. Statistically significant differences are indicated with *p < 0.05; **p < 0.01 of treatment groups by using One-way ANOVA followed by Dunnett’s post hoc tests compared to untreated group.

Back to article page